Acoustic stimulation of the brain may ease persistent symptoms after mild traumatic brain injury

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

LB Phar­ma­ceu­ti­cals, a schiz­o­phre­nia biotech de­vel­op­ing a new ver­sion of a decades-old med­i­cine, has closed a $75 mil­lion Se­ries C raise and it be­gan a

The FDA approved the first generic forms of lisdexamfetamine dimesylate (Vyvanse) capsules and chewables to treat attention deficit-hyperactivity disorder (ADHD) in patients 6 years and